Since GLP-1 RAs are often prescribed to patients with obesity, this single unmeasured factor could be the true driver of the observed risk. Demetrios Vavvas, MD, PhD Second, the results may be influenced by surveillance bias, Vavvas continued
healthcare providers wrote more than 9 million prescriptions for Wegovy, Ozempic, and other GLP-1 agonists in the last three months of 2022 alone
Prototype peptidomimetic agonists at human melanocortin receptors
With locations in Newport Beach, Laguna Hills, and Rancho Santa Margarita, Soboba offers access to weight-loss consultations, GLP-1 options, vitamin injections, and personalized support for patients seeking a more structured path forward
Delivers Long-Term Radiance, Not Temporary Glow Unlike quick-fix treatments, Japanese glutathione supports cellular repair and detoxification- helping maintain glow over time